National Comprehensive Cancer Network

About NCCN

Kimary Kulig, PhD, MPH Joins NCCN Staff as Vice President, Clinical & Translational Outcomes Research

NCCN welcomes Kimary Kulig, PhD, MPH as Vice President, Clinical & Translational Outcomes Research. Among her responsibilities, Dr. Kulig will oversee the NCCN Oncology Outcomes Database that serves both as a major clinical research repository and an analytical reporting system developed to evaluate NCCN Member Institution concordance of practice to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™).

FORT WASHINGTON, PA — The National Comprehensive Cancer Network® (NCCN®) is pleased to welcome Kimary Kulig, PhD, MPH, as Vice President, Clinical & Translational Outcomes Research. Dr. Kulig`s primary responsibility is to direct the ongoing development and advancement of the NCCN Oncology Outcomes Database (NCCN Database). The NCCN Database is a set of databases on five major tumor types with comprehensive data, including clinical outcomes, on thousands of patients treated at NCCN Member Institutions

We are excited to have Dr. Kulig, an internationally recognized expert and an experienced leader in oncology-specific outcomes research, join our staff as we look to advance the utility and productivity of the NCCN Database, said William T. McGivney, PhD, CEO of NCCN. Her extensive experience in leading oncology research programs combined with her background in biomedical research and years in the public health sector make her an ideal fit for the NCCN.

Prior to joining NCCN, Dr. Kulig worked for several years leading outcomes based research in oncology at Pfizer, Inc., most recently as Senior Director and Lead, Molecular Epidemiology Research, Oncology. In this role, Dr. Kulig designed and conducted biomarker-linked outcomes research projects in support of multiple clinical development programs, including those involving companion diagnostics, at the global level.

Prior to Dr. Kulig`s appointment at Pfizer, Inc., she led an epidemiology and surveillance research program for the Arthritis Foundation, conducted public health research at Columbia University Mailman School of Public Health and the Centers for Disease Control and Prevention (CDC), and engaged in immunology research at Columbia University`s College of Physicians and Surgeons, the Kennedy Institute of Rheumatology (London, England), and the Mayo Clinic (Rochester, MN).

Dr. Kulig holds a masters degree in public health with an emphasis in epidemiology from Columbia University Mailman School of Public Health and earned her doctorate in immunology and molecular oncology from the New York University School of Medicine.

The NCCN Database is a network-based data collection, reporting, and analytic system that describes the patterns and outcomes of care delivered in the management of patients with cancer. With the NCCN Database, NCCN seeks to implement the NCCN Guidelines™ through performance measurement. The NCCN Database is a component of NCCN Insights: Analytics, Research & Consulting. Through several tools and services, NCCN provides insight, research, and analysis on oncology patterns of care and key clinical and outcomes issues in the cancer environment.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit

The NCCN Member Institutions are:

  • Fred & Pamela Buffett Cancer Center
  • Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
  • City of Hope Comprehensive Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
  • Duke Cancer Institute
  • Fox Chase Cancer Center
  • Huntsman Cancer Institute at the University of Utah
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Mayo Clinic Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Moffitt Cancer Center
  • The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
  • Roswell Park Comprehensive Cancer Center
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
  • Stanford Cancer Institute
  • University of Alabama at Birmingham Comprehensive Cancer Center
  • UC San Diego Moores Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of Colorado Cancer Center
  • University of Michigan Rogel Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Wisconsin Carbone Cancer Center
  • Vanderbilt-Ingram Cancer Center
  • Yale Cancer Center/Smilow Cancer Hospital